Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Radionuclide Generators × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Neoplasms 1 Colorectal Neoplasms 1

Interventions

Oxaliplatin 17 Capecitabine 16 Fluorouracil 12 Bevacizumab 12 Esomeprazole 9 Sorafenib 8 Propofol 7 Leucovorin 7 Irinotecan 7 Morphine 6 Folfox protocol 6 Bismuth 6 lenvatinib 5 Sevoflurane 5 S 1 (combination) 5 Radiofrequency Ablation 5 Amoxicillin 5 sodium glycididazole 4 gadolinium ethoxybenzyl DTPA 4 fish oil triglycerides 4 ferric carboxymaltose 4 Tetracycline 4 Ribavirin 4 HMPL-013 4 Gemcitabine 4 Control Groups 4 Cetuximab 4 Celecoxib 4 regorafenib 3 raltitrexed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00510627 2017-03-03

Prometheus

Boston Scientific Corporation

Phase 4 Withdrawn

Gastrointestinal

Liver Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡